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ABSTRACT 
Schultz et al. (2004) demonstrated that 63% of the change in knee joint laxity (KJL) during a menstrual 
cycle was due to associated fluctuations in sex hormone levels.  Use of oral contraceptives modulates the 
fluctuation of sex hormone levels during the menstrual cycle and thus may reduce fluctuation in KJL 
PURPOSE: Given that increased KJL is a known risk factor for sustaining knee injuries, the purpose of this 
study was to examine the effect of oral contraceptive use on KJL during the follicular, ovulation, and luteal 
phases of the menstrual cycle. METHODS: Sixty college-age women were screened for participation and 
fourteen (20.07±1.21 years, 163.05± 9.70, and 66.81± 12.32 kg) met the inclusion criteria, provided informed 
consent, and participated in the study. Based on screening questionnaires, participants were sorted into 
groups, oral contraceptive users (OC) and non-users (NOC). Each participant’s KJL was measured on six 
occasions, five days apart. KJL was measured using a KT-1000 Knee Arthrometer at 133 N.  Measurements 
on days 1-7, 11-14, and 19-22 were used for data analysis to correspond with the three phases of the 
menstrual cycle. A 2x3 (group x phase) mixed model ANOVA was used to compare KJL between groups 
and across the three phases of the menstrual cycle.  RESULTS: KJL are reported in Table 1.  Group and 
phase did not interact to affect KJL (F(2,24)=1.92, p=0.17).  KJL did not differ between OC and NOC users 
across the menstrual cycle (F(1,12)=0.07, p=0.80), and was not different between any phase of the 
menstrual cycle (F(2,24)=0.14, p=0.87).  However, given that the spike in estradiol associated with the 
ovulation phase has been suggested to affect ligament laxity, a comparison between groups during this 
phase was conducted.   Though KJL was larger for NOC than OC, the results of a one-tailed independent 
t-test suggest that this difference was not statistically significantly  (t(12)= 1.72, p = 0.06).  However, this 
difference was characterized by a large effect size (Cohen d= 0.92) suggesting that NOC users experience 
more KJL during the ovulation phase than OC users. CONCLUSION: The results of the study indicate 
that OC may play a role in KJL. However, with limited statistical power of these analyses, additional data 
are needed to fully assess this effect. 
 
Table 1. Knee Joint Laxity Measures Across Menstrual Cycle. 
Group Joint Laxity (mm) 
Follicular Phase Ovulation Phase Luteal Phase 
OC 6.05±2.49 4.83±2.17 5.62±3.73 
NOC 5.00±1.37 6.31±2.97 6.07±2.03 
 
